On May 16, Glaxo-Smith-Kline Pharmaceuticals, the makers of
Imitrex, announced that they were releasing a new
drug for the treatment of migraines. The new drug is to be called TREXIMET and according to the makers, was to be a vast improvement over Imitrex. Like Imitrex, it is made to be taken at the onset of a migraine, but is supposed to work faster and better to reduce migraine pain.